Strom NI, Verhulst B, Bacanu SA, et al. Genome-wide association study of major anxiety disorders in 122,341 European-ancestry cases identifies 58 loci and highlights GABAergic signaling. medRxiv : the preprint server for health sciences. 2024. doi:10.1101/2024.07.03.24309466
Publications
Kim YN, Gulhan DC, Jin H, Glodzik D, Park PJ. Recent Advances in Genomic Approaches for the Detection of Homologous Recombination Deficiency. Cancer research and treatment. 2024. doi:10.4143/crt.2024.154
Kim YN, Gulhan DC, Jin H, Glodzik D, Park PJ. Recent Advances in Genomic Approaches for the Detection of Homologous Recombination Deficiency. Cancer research and treatment. 2024. doi:10.4143/crt.2024.154
Verma A, Huffman JE, Rodriguez A, et al. Diversity and scale: Genetic architecture of 2068 traits in the VA Million Veteran Program. Science (New York, N.Y.). 2024;385(6706):eadj1182. doi:10.1126/science.adj1182
Hillis AL, Martin TD, Manchester HE, et al. Targeting Cholesterol Biosynthesis with Statins Synergizes with AKT Inhibitors in Triple-Negative Breast Cancer. Cancer research. 2024. doi:10.1158/0008-5472.CAN-24-0970
Aglago EK, Qu C, Harlid S, et al. Folate intake and colorectal cancer risk according to genetic subtypes defined by targeted tumor sequencing. The American journal of clinical nutrition. 2024. doi:10.1016/j.ajcnut.2024.07.012
Hillis AL, Martin TD, Manchester HE, et al. Targeting Cholesterol Biosynthesis with Statins Synergizes with AKT Inhibitors in Triple-Negative Breast Cancer. Cancer research. 2024. doi:10.1158/0008-5472.CAN-24-0970
Pires IS, Covarrubias G, Gomerdinger VF, et al. "Target-and-release" nanoparticles for effective immunotherapy of metastatic ovarian cancer. bioRxiv : the preprint server for biology. 2024. doi:10.1101/2024.07.05.602135
Saha US, Vendruscolo M, Carpenter AE, Singh S, Bender A, Seal S. Step Forward Cross Validation for Bioactivity Prediction: Out of Distribution Validation in Drug Discovery. bioRxiv : the preprint server for biology. 2024. doi:10.1101/2024.07.02.601740
Bouley SJ, Grassetti A V, Allaway RJ, et al. Chemical genetic screens reveal defective lysosomal trafficking as synthetic lethal with NF1 loss. Journal of cell science. 2024. doi:10.1242/jcs.262343